Intravitreal Triamcinolone Acetonide Injection for Treatment of Refractory Diabetic Macular Edema. A Systematic Review

Ophthalmology

Volumn 116, Issue 5, 2009, Pages 902-913

  Yilmaz, Taygan ^a   Weaver, Christopher D ^a   Gallagher, Micheal J ^b   Cordero Coma, Miguel ^c   Cervantes Castaneda, Rene A ^d   Klisovic, Dino ^e   Lavaque, Alejandro J ^f   Larson, Robin J ^a  

^a DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^b Hermitage Medical Clinic   (Ireland)

^c HOSPITAL DE LEÓN   (Spain)

^d Departamento de Cirugía Refractiva y Segmento Anterior   (Mexico)

^e OHIO STATE UNIVERSITY   (United States)

^f Oftalmologica Cristo Alvarez   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TRIAMCINOLONE ACETONIDE;

ARTICLE; CLINICAL TRIAL; CONJUNCTIVA DISEASE; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; ENDOPHTHALMITIS; EYE INFECTION; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; LOW LEVEL LASER THERAPY; META ANALYSIS; OPHTHALMOPLEGIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA DETACHMENT; SIDE EFFECT; SYSTEMATIC REVIEW; TREATMENT RESPONSE; VISUAL ACUITY; VISUAL IMPAIRMENT;

AGED; DATABASES, FACTUAL; DIABETIC RETINOPATHY; FEMALE; GLUCOCORTICOIDS; HUMANS; INJECTIONS; INTRAOCULAR PRESSURE; MACULAR EDEMA; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VITREOUS BODY;

EID: 65349122995     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.02.002     Document Type: Article

References (24)

1. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report no. 1. Arch Ophthalmol 103 (1985) 1796-1806
2. Klein R., Klein B.E., Moss S.E., and Cruickshanks K.J. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology 102 (1995) 7-16
3. Frank R.N. Diabetic retinopathy. N Engl J Med 350 (2004) 48-58
4. Martidis A., Duker J.S., Greenberg P.B., et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109 (2002) 920-927
5. Sutter F.K., Simpson J.M., and Gillies M.C. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Ophthalmology 111 (2004) 2044-2049
6. Bonini-Filho M.A., Jorge R., Barbosa J.C., et al. Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial. Invest Ophthalmol Vis Sci 46 (2005) 3845-3849
7. Cunningham Jr. E.T., Adamis A.P., Altaweel M., et al. Macugen Diabetic Retinopathy Study Group. A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology 112 (2005) 1747-1757
8. Arevalo J.F., Fromow-Guerra J., Quiroz-Mercado H., et al. Pan-American Collaborative Retina Study Group. Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up. Ophthalmology 114 (2007) 743-750
9. Chun D.W., Heier J.S., Topping T.M., et al. A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema. Ophthalmology 113 (2006) 1706-1712
10. Higuchi A., Ogata N., Jo N., et al. Pars plana vitrectomy with removal of posterior hyaloid face in treatment of refractory diabetic macular edema resistant to triamcinolone acetonide. Jpn J Ophthalmol 50 (2006) 529-531
11. Early Treatment Diabetic Retinopathy Study Research Group. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 2. Ophthalmology 94 (1987) 761-774
12. Elman M.J., Raden R.Z., Sloan M.D., et al. Diabetic Retinopathy Clinical Research Network. A randomized trial comparing intravitreal comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology 115 (2008) 1447-1459 e1-10
13. Antcliff R.J., Spalton D.J., Stanford M.R., et al. Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology 108 (2001) 765-772
14. Jonas J.B., Degenring R.F., Kreissig I., et al. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Ophthalmology 112 (2005) 593-598
15. Gillies M.C., Simpson J.M., Luo W., et al. A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results. Arch Ophthalmol 121 (2003) 667-673
16. Lang Y., Leibu R., Shoham N., et al. Evaluation of intravitreal Kenalog toxicity in humans. Ophthalmology 114 (2007) 724-731
17. Robinson K.A., and Dickersin K. Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed. Int J Epidemiol 31 (2002) 150-153
18. Dickersin K., Scherer R., and Lefebvre C. Identifying relevant studies for systematic reviews. BMJ 309 (1994) 1286-1291
19. Jadad A.R., Moore R.A., Carroll D., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 17 (1996) 1-12
20. Cardillo J.A., Melo Jr. L.A., Costa R.A., et al. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema. Ophthalmology 112 (2005) 1557-1563
21. Audren F., Erginay A., Haouchine B., et al. Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial. Acta Ophthalmol Scand 84 (2006) 624-630
22. Dehghan M.H., Ahmadieh H., Ramezani A., et al. A randomized, placebo-controlled clinical trial of intravitreal triamcinolone for refractory diabetic macular edema. Int Ophthalmol 28 (2008) 7-17
23. Gillies M.C., Sutter F.K., Simpson J.M., et al. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial. Ophthalmology 113 (2006) 1533-1538
24. Jonas J.B., Kamppeter B.A., Harder B., et al. Intravitreal triamcinolone acetonide for diabetic macular edema: a prospective, randomized study. J Ocul Pharmacol Ther 22 (2006) 200-207